Drug information for DOPAMINE HYDROCHLORIDE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
40MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
INTL MEDICATION
18014
INJECTABLE; INJECTION
160MG/100ML
Prescription
AP (Reference Drug)
DOPAMINE HYDROCHLORIDE
Dopamine
HOSPIRA
18132
INJECTABLE; INJECTION
40MG/ML
Prescription
AP (Reference Drug)
DOPAMINE HYDROCHLORIDE
Dopamine
HOSPIRA
"
INJECTABLE; INJECTION
80MG/100ML
Prescription
AP (Reference Drug)
DOPAMINE HYDROCHLORIDE
Dopamine
HOSPIRA
"
INJECTABLE; INJECTION
80MG/ML
Prescription
AP (Reference Drug)
DOPAMINE HYDROCHLORIDE
Dopamine
HOSPIRA
"
INJECTABLE; INJECTION
40MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
WARNER CHILCOTT
18138
INJECTABLE; INJECTION
40MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
BAXTER HLTHCARE
18398
INJECTABLE; INJECTION
80MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
BAXTER HLTHCARE
"
INJECTABLE; INJECTION
40MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
LYPHOMED
18549
INJECTABLE; INJECTION
40MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
ASTRAZENECA
18656
INJECTABLE; INJECTION
40MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
SMITH AND NEPHEW
70011
INJECTABLE; INJECTION
40MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
ABRAXIS PHARM
70012
INJECTABLE; INJECTION
80MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
ABRAXIS PHARM
70013
INJECTABLE; INJECTION
40MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
SMITH AND NEPHEW
70046
INJECTABLE; INJECTION
80MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
SMITH AND NEPHEW
70047
INJECTABLE; INJECTION
40MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
ABRAXIS PHARM
70058
INJECTABLE; INJECTION
80MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
ABRAXIS PHARM
70059
INJECTABLE; INJECTION
40MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
ASTRAZENECA
70087
INJECTABLE; INJECTION
80MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
ASTRAZENECA
70089
INJECTABLE; INJECTION
80MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
ASTRAZENECA
70090
INJECTABLE; INJECTION
80MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
ASTRAZENECA
70091
INJECTABLE; INJECTION
160MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
ASTRAZENECA
70092
INJECTABLE; INJECTION
160MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
ASTRAZENECA
70093
INJECTABLE; INJECTION
160MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
ASTRAZENECA
70094
INJECTABLE; INJECTION
160MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
ABRAXIS PHARM
70364
INJECTABLE; INJECTION
40MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
WARNER CHILCOTT
70558
INJECTABLE; INJECTION
80MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
WARNER CHILCOTT
70559
INJECTABLE; INJECTION
40MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
ABBOTT
70656
INJECTABLE; INJECTION
80MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
ABBOTT
70657
INJECTABLE; INJECTION
40MG/ML
Prescription
AP (Reference Drug)
DOPAMINE HYDROCHLORIDE
Dopamine
LUITPOLD
70799
INJECTABLE; INJECTION
80MG/ML
Prescription
AP (Reference Drug)
DOPAMINE HYDROCHLORIDE
Dopamine
LUITPOLD
70820
INJECTABLE; INJECTION
160MG/ML
Prescription
AP (Reference Drug)
DOPAMINE HYDROCHLORIDE
Dopamine
LUITPOLD
70826
INJECTABLE; INJECTION
40MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
TEVA PARENTERAL
72999
INJECTABLE; INJECTION
80MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
TEVA PARENTERAL
73000
INJECTABLE; INJECTION
40MG/ML
Discontinued
DOPAMINE HYDROCHLORIDE
Dopamine
HOSPIRA
74403
Drug Adverse Effects information for DOPAMINE HYDROCHLORIDE
Role code
Indications
Reaction
# Reports
SS
ASCITES
TOXIC EPIDERMAL NECROLYSIS
1
SS
BONE MARROW TRANSPLANT
ANGIOEDEMA
3
SS
BONE MARROW TRANSPLANT
ASCITES
3
SS
BONE MARROW TRANSPLANT
OBSTRUCTIVE AIRWAYS DISORDER
3
SS
BONE MARROW TRANSPLANT
STEVENS-JOHNSON SYNDROME
3
SS
CARDIAC FAILURE
HYPERNATRAEMIA
4
SS
CARDIAC FAILURE
THIRST
4
SS
CARDIAC FAILURE
TOXIC EPIDERMAL NECROLYSIS
1
SS
ESSENTIAL HYPERTENSION
TOXIC EPIDERMAL NECROLYSIS
3
SS
FLATULENCE
TOXIC EPIDERMAL NECROLYSIS
2
SS
FLUID RETENTION
HYPERNATRAEMIA
2
SS
FLUID RETENTION
THIRST
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
ANGIOEDEMA
28
SS
PRODUCT USED FOR UNKNOWN INDICATION
ASCITES
28
SS
PRODUCT USED FOR UNKNOWN INDICATION
OBSTRUCTIVE AIRWAYS DISORDER
28
SS
PRODUCT USED FOR UNKNOWN INDICATION
STEVENS-JOHNSON SYNDROME
28
SS
PROPHYLAXIS
TOXIC EPIDERMAL NECROLYSIS
7
SS
RENAL FAILURE
TOXIC EPIDERMAL NECROLYSIS
1
SS
SEDATION
TOXIC EPIDERMAL NECROLYSIS
1
SS
SURGERY
TOXIC EPIDERMAL NECROLYSIS
1
SS
UNEVALUABLE EVENT
ANGIOEDEMA
5
SS
UNEVALUABLE EVENT
ASCITES
5
SS
UNEVALUABLE EVENT
OBSTRUCTIVE AIRWAYS DISORDER
5
SS
UNEVALUABLE EVENT
STEVENS-JOHNSON SYNDROME
5
C
ACUTE MYELOID LEUKAEMIA
ACUTE MYELOID LEUKAEMIA
2
C
ACUTE MYELOID LEUKAEMIA
CLOSTRIDIUM DIFFICILE COLITIS
2
C
ACUTE MYELOID LEUKAEMIA
PYREXIA
2
C
ACUTE MYELOID LEUKAEMIA
SEPSIS
2
C
ACUTE MYELOID LEUKAEMIA
URINARY TRACT INFECTION PSEUDOMONAL
2
C
ACUTE MYELOID LEUKAEMIA
VENOOCCLUSIVE LIVER DISEASE
2
C
ANTIBIOTIC PROPHYLAXIS
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
1
C
ANTIBIOTIC PROPHYLAXIS
CYTOMEGALOVIRUS TEST POSITIVE
2
C
ANTIBIOTIC PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
ANTIBIOTIC PROPHYLAXIS
HAEMATURIA
1
C
ANTIBIOTIC PROPHYLAXIS
INTERSTITIAL LUNG DISEASE
2
C
ANTIBIOTIC PROPHYLAXIS
SEPSIS
2
C
ANTIBIOTIC PROPHYLAXIS
THROMBOTIC MICROANGIOPATHY
1
C
ANTIBIOTIC PROPHYLAXIS
VIRAL HAEMORRHAGIC CYSTITIS
2
C
ANTICOAGULANT THERAPY
RENAL FAILURE ACUTE
1
C
ANTIFUNGAL PROPHYLAXIS
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
3
C
ANTIFUNGAL PROPHYLAXIS
CYTOMEGALOVIRUS TEST POSITIVE
6
C
ANTIFUNGAL PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
8
C
ANTIFUNGAL PROPHYLAXIS
HAEMATURIA
3
C
ANTIFUNGAL PROPHYLAXIS
INTERSTITIAL LUNG DISEASE
6
C
ANTIFUNGAL PROPHYLAXIS
SEPSIS
6
C
ANTIFUNGAL PROPHYLAXIS
THROMBOTIC MICROANGIOPATHY
3
C
ANTIFUNGAL PROPHYLAXIS
VIRAL HAEMORRHAGIC CYSTITIS
6
C
ANTIVIRAL PROPHYLAXIS
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
3
C
ANTIVIRAL PROPHYLAXIS
CYTOMEGALOVIRUS TEST POSITIVE
6
C
ANTIVIRAL PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
6
C
ANTIVIRAL PROPHYLAXIS
HAEMATURIA
3
C
ANTIVIRAL PROPHYLAXIS
INTERSTITIAL LUNG DISEASE
6
C
ANTIVIRAL PROPHYLAXIS
SEPSIS
6
C
ANTIVIRAL PROPHYLAXIS
THROMBOTIC MICROANGIOPATHY
3
C
ANTIVIRAL PROPHYLAXIS
VIRAL HAEMORRHAGIC CYSTITIS
6
C
APLASTIC ANAEMIA
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
6
C
BLOOD ANTIDIURETIC HORMONE
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
1
C
BLOOD ANTIDIURETIC HORMONE
CYTOMEGALOVIRUS TEST POSITIVE
2
C
BLOOD ANTIDIURETIC HORMONE
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
BLOOD ANTIDIURETIC HORMONE
HAEMATURIA
1
C
BLOOD ANTIDIURETIC HORMONE
INTERSTITIAL LUNG DISEASE
2
C
BLOOD ANTIDIURETIC HORMONE
SEPSIS
2
C
BLOOD ANTIDIURETIC HORMONE
THROMBOTIC MICROANGIOPATHY
1
C
BLOOD ANTIDIURETIC HORMONE
VIRAL HAEMORRHAGIC CYSTITIS
2
C
BLOOD PRESSURE DECREASED
ANAEMIA
1
C
BLOOD PRESSURE DECREASED
DISSEMINATED INTRAVASCULAR COAGULATION
1
C
BLOOD PRESSURE DECREASED
NEUTROPHIL COUNT DECREASED
1
C
BLOOD PRESSURE DECREASED
RENAL FAILURE
1
C
BLOOD PRESSURE DECREASED
SYSTEMIC CANDIDA
1
C
BONE MARROW CONDITIONING REGIMEN
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
4
C
BONE MARROW CONDITIONING REGIMEN
ACUTE MYELOID LEUKAEMIA
3
C
BONE MARROW CONDITIONING REGIMEN
BRONCHOPULMONARY ASPERGILLOSIS
9
C
BONE MARROW CONDITIONING REGIMEN
CLOSTRIDIUM DIFFICILE COLITIS
3
C
BONE MARROW CONDITIONING REGIMEN
CYTOMEGALOVIRUS TEST POSITIVE
5
C
BONE MARROW CONDITIONING REGIMEN
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
14
C
BONE MARROW CONDITIONING REGIMEN
FUNGAL INFECTION
9
C
BONE MARROW CONDITIONING REGIMEN
HAEMATURIA
4
C
BONE MARROW CONDITIONING REGIMEN
HISTIOCYTOSIS HAEMATOPHAGIC
9
C
BONE MARROW CONDITIONING REGIMEN
INTERSTITIAL LUNG DISEASE
5
C
BONE MARROW CONDITIONING REGIMEN
MULTI-ORGAN FAILURE
9
C
BONE MARROW CONDITIONING REGIMEN
PYREXIA
3
C
BONE MARROW CONDITIONING REGIMEN
SEPSIS
8
C
BONE MARROW CONDITIONING REGIMEN
THROMBOTIC MICROANGIOPATHY
4
C
BONE MARROW CONDITIONING REGIMEN
URINARY TRACT INFECTION PSEUDOMONAL
3
C
BONE MARROW CONDITIONING REGIMEN
VENOOCCLUSIVE LIVER DISEASE
1
C
BONE MARROW CONDITIONING REGIMEN
VIRAL HAEMORRHAGIC CYSTITIS
5
C
BONE MARROW FAILURE
BRONCHOPULMONARY ASPERGILLOSIS
9
C
BONE MARROW FAILURE
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
9
C
BONE MARROW FAILURE
FUNGAL INFECTION
9
C
BONE MARROW FAILURE
HISTIOCYTOSIS HAEMATOPHAGIC
9
C
BONE MARROW FAILURE
MULTI-ORGAN FAILURE
9
C
BRONCHITIS
ANAEMIA
1
C
BRONCHITIS
DISSEMINATED INTRAVASCULAR COAGULATION
1
C
BRONCHITIS
NEUTROPHIL COUNT DECREASED
1
C
BRONCHITIS
RENAL FAILURE
1
C
BRONCHITIS
SYSTEMIC CANDIDA
1
C
CANCER PAIN
ANAEMIA
1
C
CANCER PAIN
DISSEMINATED INTRAVASCULAR COAGULATION
1
C
CANCER PAIN
NEUTROPHIL COUNT DECREASED
1
C
CANCER PAIN
RENAL FAILURE
1
C
CANCER PAIN
SYSTEMIC CANDIDA
1
C
CARDIAC FAILURE
BLOOD CREATINE INCREASED
1
C
CARDIAC FAILURE
BLOOD UREA INCREASED
1
C
CARDIAC FAILURE
DEPRESSED LEVEL OF CONSCIOUSNESS
1
C
CARDIAC FAILURE
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
1
C
CARDIAC FAILURE
HYPERNATRAEMIA
1
C
CARDIAC FAILURE
HYPOVOLAEMIA
1
C
CARDIAC FAILURE CONGESTIVE
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
CARDIAC TAMPONADE
PERICARDIAL HAEMORRHAGE
1
C
COLON CANCER
ANAEMIA
2
C
COLON CANCER
DISSEMINATED INTRAVASCULAR COAGULATION
2
C
COLON CANCER
NEUTROPHIL COUNT DECREASED
2
C
COLON CANCER
RENAL FAILURE
2
C
COLON CANCER
SYSTEMIC CANDIDA
2
C
COLONY STIMULATING FACTOR THERAPY
ACUTE MYELOID LEUKAEMIA
1
C
COLONY STIMULATING FACTOR THERAPY
CLOSTRIDIUM DIFFICILE COLITIS
1
C
COLONY STIMULATING FACTOR THERAPY
PYREXIA
1
C
COLONY STIMULATING FACTOR THERAPY
SEPSIS
1
C
COLONY STIMULATING FACTOR THERAPY
URINARY TRACT INFECTION PSEUDOMONAL
1
C
CONVULSION PROPHYLAXIS
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
2
C
CONVULSION PROPHYLAXIS
CYTOMEGALOVIRUS TEST POSITIVE
4
C
CONVULSION PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
4
C
CONVULSION PROPHYLAXIS
HAEMATURIA
2
C
CONVULSION PROPHYLAXIS
INTERSTITIAL LUNG DISEASE
4
C
CONVULSION PROPHYLAXIS
SEPSIS
4
C
CONVULSION PROPHYLAXIS
THROMBOTIC MICROANGIOPATHY
2
C
CONVULSION PROPHYLAXIS
VIRAL HAEMORRHAGIC CYSTITIS
4
C
CYTOMEGALOVIRUS INFECTION
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
DIABETES MELLITUS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
DIARRHOEA
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
1
C
DISSEMINATED INTRAVASCULAR COAGULATION
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
1
C
DISSEMINATED INTRAVASCULAR COAGULATION
CYTOMEGALOVIRUS TEST POSITIVE
2
C
DISSEMINATED INTRAVASCULAR COAGULATION
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
3
C
DISSEMINATED INTRAVASCULAR COAGULATION
HAEMATURIA
1
C
DISSEMINATED INTRAVASCULAR COAGULATION
INTERSTITIAL LUNG DISEASE
2
C
DISSEMINATED INTRAVASCULAR COAGULATION
SEPSIS
2
C
DISSEMINATED INTRAVASCULAR COAGULATION
THROMBOTIC MICROANGIOPATHY
1
C
DISSEMINATED INTRAVASCULAR COAGULATION
VIRAL HAEMORRHAGIC CYSTITIS
2
C
EMERGENCY CARE
ACUTE MYELOID LEUKAEMIA
9
C
EMERGENCY CARE
CLOSTRIDIUM DIFFICILE COLITIS
9
C
EMERGENCY CARE
PYREXIA
9
C
EMERGENCY CARE
SEPSIS
9
C
EMERGENCY CARE
URINARY TRACT INFECTION PSEUDOMONAL
9
C
GRAFT VERSUS HOST DISEASE
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
1
C
GRAFT VERSUS HOST DISEASE
CYTOMEGALOVIRUS TEST POSITIVE
2
C
GRAFT VERSUS HOST DISEASE
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
GRAFT VERSUS HOST DISEASE
HAEMATURIA
1
C
GRAFT VERSUS HOST DISEASE
INTERSTITIAL LUNG DISEASE
2
C
GRAFT VERSUS HOST DISEASE
SEPSIS
2
C
GRAFT VERSUS HOST DISEASE
THROMBOTIC MICROANGIOPATHY
1
C
GRAFT VERSUS HOST DISEASE
VIRAL HAEMORRHAGIC CYSTITIS
2
C
HYPERLIPIDAEMIA
ANAEMIA
1
C
HYPERLIPIDAEMIA
DISSEMINATED INTRAVASCULAR COAGULATION
1
C
HYPERLIPIDAEMIA
NEUTROPHIL COUNT DECREASED
1
C
HYPERLIPIDAEMIA
RENAL FAILURE
1
C
HYPERLIPIDAEMIA
SYSTEMIC CANDIDA
1
C
HYPERTENSION
ANAEMIA
2
C
HYPERTENSION
DISSEMINATED INTRAVASCULAR COAGULATION
2
C
HYPERTENSION
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
HYPERTENSION
NEUTROPHIL COUNT DECREASED
2
C
HYPERTENSION
RENAL FAILURE
2
C
HYPERTENSION
SYSTEMIC CANDIDA
2
C
HYPERVENTILATION
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
2
C
HYPERVENTILATION
CYTOMEGALOVIRUS TEST POSITIVE
4
C
HYPERVENTILATION
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
4
C
HYPERVENTILATION
HAEMATURIA
2
C
HYPERVENTILATION
INTERSTITIAL LUNG DISEASE
4
C
HYPERVENTILATION
SEPSIS
4
C
HYPERVENTILATION
THROMBOTIC MICROANGIOPATHY
2
C
HYPERVENTILATION
VIRAL HAEMORRHAGIC CYSTITIS
4
C
HYPOPHAGIA
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
10
C
INFECTION
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
1
C
INFECTION PROPHYLAXIS
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
3
C
INFECTION PROPHYLAXIS
ACUTE MYELOID LEUKAEMIA
3
C
INFECTION PROPHYLAXIS
CLOSTRIDIUM DIFFICILE COLITIS
3
C
INFECTION PROPHYLAXIS
CYTOMEGALOVIRUS TEST POSITIVE
6
C
INFECTION PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
6
C
INFECTION PROPHYLAXIS
HAEMATURIA
3
C
INFECTION PROPHYLAXIS
INTERSTITIAL LUNG DISEASE
6
C
INFECTION PROPHYLAXIS
PYREXIA
3
C
INFECTION PROPHYLAXIS
SEPSIS
9
C
INFECTION PROPHYLAXIS
THROMBOTIC MICROANGIOPATHY
3
C
INFECTION PROPHYLAXIS
URINARY TRACT INFECTION PSEUDOMONAL
3
C
INFECTION PROPHYLAXIS
VIRAL HAEMORRHAGIC CYSTITIS
6
C
INSOMNIA
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
5
C
INTRACRANIAL HYPOTENSION
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
1
C
INTRACRANIAL HYPOTENSION
CYTOMEGALOVIRUS TEST POSITIVE
2
C
INTRACRANIAL HYPOTENSION
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
INTRACRANIAL HYPOTENSION
HAEMATURIA
1
C
INTRACRANIAL HYPOTENSION
INTERSTITIAL LUNG DISEASE
2
C
INTRACRANIAL HYPOTENSION
SEPSIS
2
C
INTRACRANIAL HYPOTENSION
THROMBOTIC MICROANGIOPATHY
1
C
INTRACRANIAL HYPOTENSION
VIRAL HAEMORRHAGIC CYSTITIS
2
C
METASTATIC GASTRIC CANCER
ABDOMINAL ADHESIONS
1
C
METASTATIC GASTRIC CANCER
ABDOMINAL PAIN
1
C
METASTATIC GASTRIC CANCER
ANAEMIA
1
C
METASTATIC GASTRIC CANCER
DEHYDRATION
1
C
METASTATIC GASTRIC CANCER
DEPRESSED LEVEL OF CONSCIOUSNESS
1
C
METASTATIC GASTRIC CANCER
DIARRHOEA
1
C
METASTATIC GASTRIC CANCER
FATIGUE
1
C
METASTATIC GASTRIC CANCER
GASTROINTESTINAL PERFORATION
1
C
METASTATIC GASTRIC CANCER
ILEUS
1
C
METASTATIC GASTRIC CANCER
INTERNAL HERNIA
1
C
METASTATIC GASTRIC CANCER
INTESTINAL OBSTRUCTION
1
C
METASTATIC GASTRIC CANCER
NAUSEA
1
C
METASTATIC GASTRIC CANCER
OEDEMA PERIPHERAL
1
C
METASTATIC GASTRIC CANCER
PYREXIA
1
C
METASTATIC GASTRIC CANCER
STOMATITIS
1
C
METASTATIC GASTRIC CANCER
VOMITING
1
C
MULTIPLE MYELOMA
SEPSIS
2
C
MULTIPLE MYELOMA
WHITE BLOOD CELL COUNT DECREASED
2
C
NEUROLEPTIC MALIGNANT SYNDROME
HEPATITIS FULMINANT
1
C
OEDEMA
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
1
C
OEDEMA
CYTOMEGALOVIRUS TEST POSITIVE
2
C
OEDEMA
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
3
C
OEDEMA
HAEMATURIA
1
C
OEDEMA
INTERSTITIAL LUNG DISEASE
2
C
OEDEMA
SEPSIS
2
C
OEDEMA
THROMBOTIC MICROANGIOPATHY
1
C
OEDEMA
VIRAL HAEMORRHAGIC CYSTITIS
2
C
ORAL CANDIDIASIS
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
1
C
ORAL CANDIDIASIS
CYTOMEGALOVIRUS TEST POSITIVE
2
C
ORAL CANDIDIASIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
ORAL CANDIDIASIS
HAEMATURIA
1
C
ORAL CANDIDIASIS
INTERSTITIAL LUNG DISEASE
2
C
ORAL CANDIDIASIS
SEPSIS
2
C
ORAL CANDIDIASIS
THROMBOTIC MICROANGIOPATHY
1
C
ORAL CANDIDIASIS
VIRAL HAEMORRHAGIC CYSTITIS
2
C
OROPHARYNGEAL PAIN
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
1
C
OSTEOPOROSIS PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
1
C
PLATELET COUNT DECREASED
BRONCHOPULMONARY ASPERGILLOSIS
9
C
PLATELET COUNT DECREASED
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
9
C
PLATELET COUNT DECREASED
FUNGAL INFECTION
9
C
PLATELET COUNT DECREASED
HISTIOCYTOSIS HAEMATOPHAGIC
9
C
PLATELET COUNT DECREASED
MULTI-ORGAN FAILURE
9
C
PLATELET COUNT DECREASED
RENAL FAILURE ACUTE
1
C
PNEUMONIA
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
PNEUMONIA FUNGAL
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
1
C
PNEUMONIA FUNGAL
CYTOMEGALOVIRUS TEST POSITIVE
2
C
PNEUMONIA FUNGAL
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
PNEUMONIA FUNGAL
HAEMATURIA
1
C
PNEUMONIA FUNGAL
INTERSTITIAL LUNG DISEASE
2
C
PNEUMONIA FUNGAL
SEPSIS
2
C
PNEUMONIA FUNGAL
THROMBOTIC MICROANGIOPATHY
1
C
PNEUMONIA FUNGAL
VIRAL HAEMORRHAGIC CYSTITIS
2
C
PREMEDICATION
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
1
C
PREMEDICATION
ACUTE MYELOID LEUKAEMIA
2
C
PREMEDICATION
ANAEMIA
2
C
PREMEDICATION
BRONCHOPULMONARY ASPERGILLOSIS
18
C
PREMEDICATION
CLOSTRIDIUM DIFFICILE COLITIS
2
C
PREMEDICATION
CYTOMEGALOVIRUS TEST POSITIVE
2
C
PREMEDICATION
DISSEMINATED INTRAVASCULAR COAGULATION
2
C
PREMEDICATION
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
20
C
PREMEDICATION
FUNGAL INFECTION
18
C
PREMEDICATION
HAEMATURIA
1
C
PREMEDICATION
HISTIOCYTOSIS HAEMATOPHAGIC
18
C
PREMEDICATION
INTERSTITIAL LUNG DISEASE
2
C
PREMEDICATION
MULTI-ORGAN FAILURE
18
C
PREMEDICATION
NEUTROPHIL COUNT DECREASED
2
C
PREMEDICATION
PYREXIA
2
C
PREMEDICATION
RENAL FAILURE
2
C
PREMEDICATION
SEPSIS
4
C
PREMEDICATION
SYSTEMIC CANDIDA
2
C
PREMEDICATION
THROMBOTIC MICROANGIOPATHY
1
C
PREMEDICATION
URINARY TRACT INFECTION PSEUDOMONAL
2
C
PREMEDICATION
VIRAL HAEMORRHAGIC CYSTITIS
2
C
PRODUCT USED FOR UNKNOWN INDICATION
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
1
C
PRODUCT USED FOR UNKNOWN INDICATION
BRONCHOPULMONARY ASPERGILLOSIS
261
C
PRODUCT USED FOR UNKNOWN INDICATION
CYTOMEGALOVIRUS TEST POSITIVE
2
C
PRODUCT USED FOR UNKNOWN INDICATION
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
263
C
PRODUCT USED FOR UNKNOWN INDICATION
FUNGAL INFECTION
261
C
PRODUCT USED FOR UNKNOWN INDICATION
HAEMATURIA
1
C
PRODUCT USED FOR UNKNOWN INDICATION
HISTIOCYTOSIS HAEMATOPHAGIC
261
C
PRODUCT USED FOR UNKNOWN INDICATION
INTERSTITIAL LUNG DISEASE
2
C
PRODUCT USED FOR UNKNOWN INDICATION
MULTI-ORGAN FAILURE
261
C
PRODUCT USED FOR UNKNOWN INDICATION
SEPSIS
2
C
PRODUCT USED FOR UNKNOWN INDICATION
THROMBOTIC MICROANGIOPATHY
1
C
PRODUCT USED FOR UNKNOWN INDICATION
VENOOCCLUSIVE LIVER DISEASE
38
C
PRODUCT USED FOR UNKNOWN INDICATION
VIRAL HAEMORRHAGIC CYSTITIS
2
C
PROPHYLAXIS
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
3
C
PROPHYLAXIS
ACUTE MYELOID LEUKAEMIA
1
C
PROPHYLAXIS
BRONCHOPULMONARY ASPERGILLOSIS
72
C
PROPHYLAXIS
CLOSTRIDIUM DIFFICILE COLITIS
1
C
PROPHYLAXIS
CYTOMEGALOVIRUS TEST POSITIVE
6
C
PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
84
C
PROPHYLAXIS
FUNGAL INFECTION
72
C
PROPHYLAXIS
HAEMATURIA
3
C
PROPHYLAXIS
HISTIOCYTOSIS HAEMATOPHAGIC
72
C
PROPHYLAXIS
INTERSTITIAL LUNG DISEASE
6
C
PROPHYLAXIS
MULTI-ORGAN FAILURE
72
C
PROPHYLAXIS
PERICARDIAL HAEMORRHAGE
3
C
PROPHYLAXIS
PYREXIA
1
C
PROPHYLAXIS
SEPSIS
10
C
PROPHYLAXIS
THROMBOTIC MICROANGIOPATHY
3
C
PROPHYLAXIS
URINARY TRACT INFECTION PSEUDOMONAL
1
C
PROPHYLAXIS
VIRAL HAEMORRHAGIC CYSTITIS
6
C
PROPHYLAXIS
WHITE BLOOD CELL COUNT DECREASED
3
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
3
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
CYTOMEGALOVIRUS TEST POSITIVE
6
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
9
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
HAEMATURIA
3
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
INTERSTITIAL LUNG DISEASE
6
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
SEPSIS
6
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
THROMBOTIC MICROANGIOPATHY
3
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
VIRAL HAEMORRHAGIC CYSTITIS
6
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
3
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
ACUTE MYELOID LEUKAEMIA
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
CLOSTRIDIUM DIFFICILE COLITIS
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
CYTOMEGALOVIRUS TEST POSITIVE
5
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
5
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
HAEMATURIA
3
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
INTERSTITIAL LUNG DISEASE
5
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
PYREXIA
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
SEPSIS
7
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
THROMBOTIC MICROANGIOPATHY
3
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
URINARY TRACT INFECTION PSEUDOMONAL
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
VIRAL HAEMORRHAGIC CYSTITIS
5
C
PROSTATE CANCER
RENAL FAILURE ACUTE
2
C
PYREXIA
ANAEMIA
5
C
PYREXIA
DISSEMINATED INTRAVASCULAR COAGULATION
5
C
PYREXIA
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
3
C
PYREXIA
NEUTROPHIL COUNT DECREASED
5
C
PYREXIA
RENAL FAILURE
5
C
PYREXIA
SYSTEMIC CANDIDA
5
C
RED BLOOD CELL COUNT DECREASED
BRONCHOPULMONARY ASPERGILLOSIS
9
C
RED BLOOD CELL COUNT DECREASED
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
9
C
RED BLOOD CELL COUNT DECREASED
FUNGAL INFECTION
9
C
RED BLOOD CELL COUNT DECREASED
HISTIOCYTOSIS HAEMATOPHAGIC
9
C
RED BLOOD CELL COUNT DECREASED
MULTI-ORGAN FAILURE
9
C
SEDATION
BLOOD PRESSURE DECREASED
1
C
SEDATION
BRADYCARDIA
1
C
SEDATION
CARDIAC ARREST
1
C
SEDATION
MELAENA
1
C
SEPSIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
4
C
SUPPLEMENTATION THERAPY
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
1
C
SUPPLEMENTATION THERAPY
CYTOMEGALOVIRUS TEST POSITIVE
2
C
SUPPLEMENTATION THERAPY
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
SUPPLEMENTATION THERAPY
HAEMATURIA
1
C
SUPPLEMENTATION THERAPY
INTERSTITIAL LUNG DISEASE
2
C
SUPPLEMENTATION THERAPY
SEPSIS
2
C
SUPPLEMENTATION THERAPY
THROMBOTIC MICROANGIOPATHY
1
C
SUPPLEMENTATION THERAPY
VIRAL HAEMORRHAGIC CYSTITIS
2
C
SYSTEMIC MYCOSIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
1
C
TACHYCARDIA
ANAEMIA
1
C
TACHYCARDIA
DISSEMINATED INTRAVASCULAR COAGULATION
1
C
TACHYCARDIA
NEUTROPHIL COUNT DECREASED
1
C
TACHYCARDIA
RENAL FAILURE
1
C
TACHYCARDIA
SYSTEMIC CANDIDA
1
C
WHITE BLOOD CELL COUNT DECREASED
RENAL FAILURE ACUTE
1
C
WHITE BLOOD CELL COUNT INCREASED
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN
2
C
WHITE BLOOD CELL COUNT INCREASED
CYTOMEGALOVIRUS TEST POSITIVE
4
C
WHITE BLOOD CELL COUNT INCREASED
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
4
C
WHITE BLOOD CELL COUNT INCREASED
HAEMATURIA
2
C
WHITE BLOOD CELL COUNT INCREASED
INTERSTITIAL LUNG DISEASE
4
C
WHITE BLOOD CELL COUNT INCREASED
SEPSIS
4
C
WHITE BLOOD CELL COUNT INCREASED
THROMBOTIC MICROANGIOPATHY
2
C
WHITE BLOOD CELL COUNT INCREASED
VIRAL HAEMORRHAGIC CYSTITIS
4
Ads by Google